Charles J Ryan, MD, is a Professor of Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF). He is the Leader of the Genitourinary Medical Oncology Program, overseeing the clinical research efforts of a group of nine genitourinary medical oncologists conducting clinical trials in prostate, kidney and bladder cancer. Within UCSF he is the Chairs the Genitourinary Oncology Clinical Research Site Committee and the Committee on Human Research (IRB). Nationally, he serves as Co-Chair of the National Cancer Institute’s GU Steering Committee Prostate Cancer Task Force and is a member of the National Comprehensive Cancer Network (NCCN) Kidney/Testicular Cancer Guideline Panel, and the Leader of the Advanced Prostate Cancer Cadre in the Alliance for Clinical Trials in Oncology. He also serves on the editorial board of the Journal of Clinical Oncology and other journals.
He is internationally known for his clinical research in castration resistant prostate cancer (CRPC) and has over 75 peer reviewed publications. Dr Ryan led the Phase I, II and III studies with abiraterone acetate that defined its use in patients with CRPC who have not received chemotherapy. Dr Ryan has published extensively on correlative markers in prostate cancer as well as a series of other phase I and II studies with novel targeted agents and immunotherapies. In addition to this research, he has lectured internationally and has served as an advisor to numerous biotech and pharma companies.
Dr. Ryan attended Marquette University where he received a BA in Philosophy, magna cum laude, and was elected to Phi Beta Kappa. He received his MD from the University of Wisconsin and completed residency in internal medicine at the University of Wisconsin Hospital and Clinics, where he also served as a Chief Resident. He completed a fellowship in medical oncology in the Department of Medicine at Memorial Sloan-Kettering Cancer Center and the Joan and Sanford I. Weil Medical College of Cornell University in New York. He joined the faculty at UCSF in 2003.